A health products maker which is listed on the New York Stock Exchange has agreed to acquire a US counterpart, including its UK base in Nottingham. Catalent is to snap up Juniper Pharmaceuticals, which is listed on the NASDAQ, together with its Juniper Pharma Services division in the East Midlands....
Transporting Drugs Safely and Securely
Leicestershire based Uvamed Ltd have been working alongside local anaesthetists and pharmacists, to find solutions for safe auditable storage and transportation of controlled drugs between secure locations. The new Tamper Evident Rainbow Tray™ is proving to be the ideal solution, allowing anaesthetists and nurses to draw up their drugs in...
Five major UK Life Sciences Membership Associations team up to lobby parliament regarding Entrepreneurs’ Relief
OBN, OneNucleus, BioNow, Medilink Midlands and MediWales, major not-for-profit life sciences membership organisations in the UK, which together represent around 2,000 active life sciences companies, have sent an open letter on Friday 22 June to the Chancellor of the Exchequer the...
Juniper Pharma Services expands laboratory facilities to meet with growing demand
Nottingham, UK – Juniper Pharma Services (JPS), a Contract Development and Manufacturing Organisation (CDMO) specialising in the development of challenging small molecules, has announced a significant expansion to its UK-based drug development and clinical trial manufacturing facilities. The extension provides four additional process development laboratories at its Nottingham site, improving...
SEHTA Launch of the Accessing the NHS Guide
SEHTA (South East Health Technologies Alliance) is pleased to announce the release of our Accessing the NHS: a guide for SMEs, supported by Hempsons, which was launched on Wednesday 13th June at this year’s, SEHTA AGM & Annual Conference, which took place in Westminster, London. Most health technology companies want...
£2.5bn British Patient Capital Programme Launched to Enable Long-Term Investment in Innovative Companies across the UK
The British Business Bank is launching British Patient Capital, a new £2.5bn programme designed to enable long-term investment in high growth potential companies across the UK led by ambitious entrepreneurs who want to build successful, world-class businesses. The creation of the £2.5bn programme is one of the key outcomes of...
Five Life Science companies celebrate success at the Medilink East Midlands Business Awards
Five companies from across the region were delighted to be selected as winners at last night’s Medilink East Midlands Business Awards. The Awards, which are held as part of the region’s premier life science event, Innovation Day, recognise organisations in the sector who in the past year have excelled in...
The UK’s first Life Sciences Opportunities Zone praised at ministerial visit
The Rt Hon Lord Henley, Parliamentary Under Secretary of State at the Department for Business, Energy and Industrial Strategy (BEIS) endorsed the UK’s first Life Sciences Opportunities Zone during a visit to Charnwood Campus, Loughborough on Friday 1 June. Lord Henley met with The Rt Hon Nicky Morgan MP for...
First deal completed from Midlands Engine Investment Fund
A regenerative medicine business has become the first to receive £2m as part of a Midlands Engine Investment Fund which was launched in February by Sajid Javid. Nottingham-based Locate Therapeutics has received the first equity investment from the Proof of Concept & Early Stage Fund. Part of a £2m finance...
ABHI Expands US ‘Innovation Hub’
ABHI has taken another important step in supporting UK HealthTech companies do business in the US. Following its launch six months ago, ABHI’s Innovation Hub has proven to be of significant benefit to UK companies. As a result, the Hub will now be expanded to accommodate double the number of...
